Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Myriad Genetics buy The Goldman Sachs Group, Inc.

Start price
€21.20
23.05.23 / 50%
Target price
€23.22
23.05.24
Performance (%)
0.94%
End price
€21.40
24.05.24
Summary
This prediction ended on 24.05.24 with a price of €21.40. The BUY prediction by The_Goldman_Sachs_Gr for Myriad Genetics closed nearly unchanged. The_Goldman_Sachs_Gr has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Myriad Genetics -2.362% -2.362% 50.303%
iShares Core DAX® 1.056% 1.056% 18.108%
iShares Nasdaq 100 -1.886% -0.160% 26.970%
iShares Nikkei 225® 2.553% 4.359% 17.676%
iShares S&P 500 -0.434% 0.224% 24.986%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Myriad Genetics diskutieren
Prediction Buy
Perf. (%) 0.94%
Target price 23.218
Change
Ends at 23.05.24

Myriad Genetics, Inc. (NASDAQ: MYGN) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "buy" rating. They now have a $25.00 price target on the stock, up previously from $18.00.
Ratings data for MYGN provided by MarketBeat

In the thread Trading Myriad Genetics
Prediction Buy
Perf. (%) 0.94%
Target price 23.218
Change
Ends at 23.05.24

Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten

Current prediction by The_Goldman_Sachs_Gr for Myriad Genetics

buy
Myriad Genetics

Start price
Target price
Perf. (%)
€21.00
29.01.24
€28.68
29.01.25
19.05%
26.08.24

Stopped prediction by The_Goldman_Sachs_Gr for Myriad Genetics

buy
Myriad Genetics

Start price
Target price
Perf. (%)
€20.80
21.07.23
€25.14
21.07.24
14.42%
22.07.24